MedPath

Comparison of Balanced Crystalloids and Normal Saline in Septic Patients

Not Applicable
Conditions
Sepsis
Acute Kidney Injury
Septic Shock
Sepsis, Severe
Interventions
Drug: lactated Ringer's solution
Drug: 0.9% saline
Registration Number
NCT03685214
Lead Sponsor
ZhiYong Peng
Brief Summary

In this prospective randomized controlled trial, investigators attempt to study the effects of acetated Ringer's solution on the prognosis and renal function of patients with sepsis in intensive care unit compared with normal saline, and provide evidence for current fluid resuscitation strategies for sepsis.

Detailed Description

During the study period,either normal saline or acetated Ringer's solution will be assigned as resuscitation fluid to the septic patients meeting the inclusion criteria.It is anticipated that about 500 patients will be enrolled during the study period.

Recruitment & Eligibility

Status
UNKNOWN
Sex
All
Target Recruitment
500
Inclusion Criteria
  • Patients diagnosed sepsis aged 18~75 and accepted therapy in ICU
Exclusion Criteria
  • Need of Renal replacement treatment
  • End-stage renal failure
  • pregnant woman

Study & Design

Study Type
INTERVENTIONAL
Study Design
CROSSOVER
Arm && Interventions
GroupInterventionDescription
Balanced Crystalloidslactated Ringer's solutionWe use acetated Ringer's solution for resuscitation fluid in ICU septic patients
0.9% saline0.9% salineWe use 0.9% saline for resuscitation fluid in ICU septic patients
Primary Outcome Measures
NameTimeMethod
Development of kidney injury as defined by the KDIGO criteria.5 days after the admission

Investigators will use the level of creatinine(μmol/L) and body weight adjusted urine(ml/h/kg) for severity assessment of kidney injury

Need of renal replacement treatmentAfter the admission and before the discharge from ICU,average 15 days

Investigators will assess patients' kidney function everyday

Secondary Outcome Measures
NameTimeMethod
ICU stayAfter the admission and before the discharge from ICU,average 15 days

the time of patients' requirement for critical care

28 days mortality28 days after the admission in ICU

the short time mortality

Trial Locations

Locations (1)

Zhongnan Hospital

🇨🇳

Wuhan, Hubei, China

© Copyright 2025. All Rights Reserved by MedPath